Promoting human health and safety by reducing exposures to risks and harms through regulatory interventions is among the most important responsibilities of the government. Such efforts encompass a wide array of activities in many different contexts: improving air and water quality; safeguarding the food supply; reducing the risk of injury on the job, in transportation, and from consumer products; and minimizing exposure to toxic chemicals. Estimating the magnitude of the expected health and longevity benefits and reductions in mortality, morbidity, and injury risks helps policy makers decide whether particular interventions merit the expected costs associated with achieving these benefits and inform their choices among alternative strategies. Valuing Health for Regulatory Cost-Effectiveness Analysis provides useful recommendations for how to measure health-related quality of- life impacts for diverse public health, safety, and environmental regulations. Public decision makers, regulatory analysts, scholars, and students in the field will find this an essential review text.It will become a standard reference for all government agencies and those consultants and contractors who support the work of regulatory programs.
Wilhelmine Miller, Lisa A. Robinson, and Robert S. Lawrence, Editors, Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation
1 Front Matter; 2 Executive Summary; 3 1 Introduction; 4 2 Characteristics of Major Regulations and Current Analytic Practices; 5 3 Measures and Strategies for Obtaining Health Benefit Values for Regulatory Analysis; 6 4 Beyond Ratios: Ethical and Nonquantifiable Aspects of Regulatory Decisions; 7 5 Recommendations for Regulatory Cost-Effectiveness Analysis; 8 Appendix A Summary of Case Studies; 9 Appendix B Health Indexes; 10 Appendix C OMB Circular A-4; 11 Appendix D Acronyms and Glossary; 12 Appendix E Biographical Sketches; 13 References; 14 Index
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, National Research Council, and Families Board on Children, Youth, and Healthy Development Committee on Adolescent Health Care Services and Models of Care for Treatment, Prevention, Leslie J. Sim, Jennifer Appleton Gootman, Robert S. Lawrence
Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee to Study Priorities for Vaccine Development, Robert S. Lawrence, Jane S. Durch, Kathleen R. Stratton